Thomas Steyer’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Thomas Steyer’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,160,000	Closed	-$87.3M	–	324
2022 Q2	$87.3M	Buy	+1,160,000	New	+$51.6M	0.47%	59
2021 Q3	–	Sell	-465,000	Closed	-$36.3M	–	321
2021 Q2	$36.3M	Sell	465,000 -35,000	-7%	-$2.59M	0.15%	84
2021 Q1	$47.3M	Buy	+500,000	New	+$59.5M	0.24%	75

Thomas Steyer's TPTX Position: Q3 2022 in Review

Thomas Steyer sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 1,160,000 shares — an estimated $87.3M sold.

Thomas Steyer first reported a position in TPTX in Q1 2021 and held it in 3 quarters. The position peaked at $87.3M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Thomas Steyer reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Thomas Steyer sold 1,160,000 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $87.3M.
Thomas Steyer first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Thomas Steyer's Turning Point Therapeutics, Inc. Common Stock position peaked at $87.3M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Farallon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.